Domera Labs builds Ami, the first AI companion for seniors. Ami brings the power of a smartphone into a more human form: voice-first and deeply personalized
We at Domera Labs are rethinking human-machine interaction from first principles by introducing a better interface to interact with technology: voice
By combining the most intuitive hardware design with frontier AI, Ami makes AI accessible for the fastest growing demographic worldwide. The goal is to make the everyday life older adults more seamless, while addressing that generation's biggest challenge: loneliness and isolation. With Ami we are building the category leader of a new hardware paradigm by building a full standalone device (and not a gadget) that aims to makes the smartphones of today redundant.
A builder's mindset: ship > fail > learn > improve
Stay focused when multiple priorities compete and the ranking is unclear
Work seamlessly across operations and engineering
Can navigate ambiguity and make progress in fast-moving research environments
Founding-team equity and a real say in technical direction
A product with signed launch partners, not a demo in search of a market
A small team, short decision paths
Opportunity to shape the future of hardware and socially intelligent AI models
Similar Jobs
What you need to know about the San Francisco Tech Scene
Key Facts About San Francisco Tech
- Number of Tech Workers: 365,500; 13.9% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Google, Apple, Salesforce, Meta
- Key Industries: Artificial intelligence, cloud computing, fintech, consumer technology, software
- Funding Landscape: $50.5 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Sequoia Capital, Andreessen Horowitz, Bessemer Venture Partners, Greylock Partners, Khosla Ventures, Kleiner Perkins
- Research Centers and Universities: Stanford University; University of California, Berkeley; University of San Francisco; Santa Clara University; Ames Research Center; Center for AI Safety; California Institute for Regenerative Medicine



